FREE SHIPPING | SAME DAY DISPATCH | AUSTRALIAN STOCK

Weight Management Research

RetaPep’s Weight Management Research category features investigational compounds studied for metabolic regulation, adiposity reduction, and energy homeostasis at the receptor level. Products include Retatrutide in 10mg, 30mg, and 60mg formats, and MOTS-c.

Retatrutide (LY3437943) is an investigational triple hormone receptor agonist simultaneously targeting GLP-1, GIP, and glucagon receptors — a mechanism that distinguishes it from dual-agonist compounds. It has been studied in preclinical and early clinical research contexts for its effects on energy expenditure, body weight regulation, and metabolic function.

MOTS-c is a mitochondrial-derived peptide studied for its role as an exercise mimetic — researched for metabolic flexibility, insulin sensitivity, and body composition regulation in aging and metabolic disease models.

All compounds are supplied as lyophilised powder at >=99% purity with Certificate of Analysis documentation. For preclinical and in vitro research purposes only. Not approved for clinical or therapeutic use. Fast dispatch from Byron Bay, NSW.

Showing all 4 resultsSorted by popularity